doi: 10.1016/S0140-6736(04)16513-6.
Dangers of rosuvastatin identified before and after FDA approval
- PMID: 15220045
- DOI: 10.1016/S0140-6736(04)16513-6
Item in Clipboard
Dangers of rosuvastatin identified before and after FDA approval
Lancet.
.
No abstract available
Comment in
-
Safety and efficacy of rosuvastatin.Lancet. 2004 Jul 10-16;364(9429):135. doi: 10.1016/S0140-6736(04)16616-6. Lancet. 2004. PMID: 15246717 No abstract available.
-
Should rosuvastatin be withdrawn from the market?Lancet. 2004 Oct 30-Nov 5;364(9445):1577-8; author reply 1578-9. doi: 10.1016/S0140-6736(04)17302-9. Lancet. 2004. PMID: 15519620 No abstract available.
-
Should rosuvastatin be withdrawn from the market?Lancet. 2004 Oct 30-Nov 5;364(9445):1577; author reply 1578-9. doi: 10.1016/S0140-6736(04)17301-7. Lancet. 2004. PMID: 15519621 No abstract available.
-
Should rosuvastatin be withdrawn from the market?Lancet. 2004 Oct 30-Nov 5;364(9445):1579; discussion 1579-80. doi: 10.1016/S0140-6736(04)17304-2. Lancet. 2004. PMID: 15519624 No abstract available.
Similar articles
-
Safety and efficacy of rosuvastatin.Lancet. 2004 Jul 10-16;364(9429):135. doi: 10.1016/S0140-6736(04)16616-6. Lancet. 2004. PMID: 15246717 No abstract available.
-
Pressure group urges rosuvastatin recall.Lancet. 2004 Mar 13;363(9412):871. doi: 10.1016/S0140-6736(04)15777-2. Lancet. 2004. PMID: 15032242 No abstract available.
-
Rosuvastatin: winner in the statin wars, patients' health notwithstanding.BMJ. 2015 Mar 17;350:h1388. doi: 10.1136/bmj.h1388. BMJ. 2015. PMID: 25787130 No abstract available.
-
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.Expert Opin Drug Saf. 2004 Nov;3(6):547-57. doi: 10.1517/14740338.3.6.547. Expert Opin Drug Saf. 2004. PMID: 15500414 Review.
-
Rosuvastatin: an independent analysis of risks and benefits.MedGenMed. 2006 Jun 14;8(2):73. MedGenMed. 2006. PMID: 16926812 Free PMC article. Review.
Cited by
-
A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.PLoS One. 2012;7(8):e42866. doi: 10.1371/journal.pone.0042866. Epub 2012 Aug 22. PLoS One. 2012. PMID: 22936996 Free PMC article.
-
Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia.Lipids. 2008 Mar;43(3):231-41. doi: 10.1007/s11745-007-3142-5. Epub 2008 Jan 10. Lipids. 2008. PMID: 18196308
-
Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system.Clin Pharmacol Ther. 2012 Jul;92(1):80-6. doi: 10.1038/clpt.2011.369. Epub 2012 May 16. Clin Pharmacol Ther. 2012. PMID: 22588606 Free PMC article.
-
Drug development: how academia, industry and authorities interact.Nat Rev Nephrol. 2014 Oct;10(10):602-10. doi: 10.1038/nrneph.2014.133. Epub 2014 Aug 5. Nat Rev Nephrol. 2014. PMID: 25092151 Review.
-
Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.PLoS One. 2011;6(12):e28124. doi: 10.1371/journal.pone.0028124. Epub 2011 Dec 20. PLoS One. 2011. PMID: 22205938 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
